Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) vs Greenlane Holdings, Inc. (GNLN)
A side-by-side comparison of Park Ha Biological Technology Co., Ltd. Ordinary Shares and Greenlane Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BYAH
Park Ha Biological Technology Co., Ltd. Ordinary Shares
$2.35Consumer DefensiveDelayed quote: Oct 6, 2026, 12:11 PM EDT
GNLN
Greenlane Holdings, Inc.
$3.25Consumer DefensiveDelayed quote: Oct 6, 2026, 12:11 PM EDT
Total return — BYAH vs GNLN
growth of $100 · dividends reinvested · last 1yBYAH -98.8% (-98.8%/yr)GNLN -91.7% (-91.7%/yr)GNLN compounded faster over this window
Log scale — wide-divergence pair
BYAH GNLN
BYAH vs GNLN: by the numbers
- •BYAH is the larger company ($2M vs $610254 market cap).
- •Both run net losses; BYAH's is the smaller (-214.17% vs -4143.38% net margin).
Metrics side by side
Valuation
| Metric | BYAH | GNLN |
|---|---|---|
| P/S ratio | 0.46 | 0.21 |
| P/B ratio | 0.33 | 0.02 |
Profitability
| Metric | BYAH | GNLN |
|---|---|---|
| Gross margin | 89.94% | -286.22% |
| Operating margin | -956.45% | -1245.60% |
| Net margin | -214.17% | -4143.38% |
| ROE | -151.66% | -477.54% |
| ROIC | -145.22% | -221.21% |
Growth (annualized)
| Metric | BYAH | GNLN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -53.89% |
| Total return CAGR (5Y) | N/A | -96.12% |
Go deeper
Dig into the metrics
Park Ha Biological Technology Co., Ltd. Ordinary Shares ROEGreenlane ROEPark Ha Biological Technology Co., Ltd. Ordinary Shares operating marginGreenlane operating marginPark Ha Biological Technology Co., Ltd. Ordinary Shares revenue growthGreenlane revenue growthPark Ha Biological Technology Co., Ltd. Ordinary Shares free cash flowGreenlane free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.